Anoxia is necessary for tumor cell toxicity caused by a low-oxygen environment

被引:122
作者
Papandreou, I [1 ]
Krishna, C [1 ]
Kaper, F [1 ]
Cai, DL [1 ]
Giaccia, AJ [1 ]
Denko, NC [1 ]
机构
[1] Stanford Univ, Sch Med, Dept Radiat Oncol, Div Radiat & Canc Biol, Stanford, CA 94305 USA
关键词
D O I
10.1158/0008-5472.CAN-04-3395
中图分类号
R73 [肿瘤学];
学科分类号
100214 [肿瘤学];
摘要
Cells exposed to oxygen deprivation in vitro have been shown to reduce proliferation and/or engage in programmed cell death. There is considerable controversy in the literature as to the role of hypoxia-inducible factor-1 (HIF-1) and HIF-1 target genes in initiating these responses. We therefore examined the oxygen dependence and the role of the hypoxia-responsive transcription factor HIF-1 in making the cellular death decision. Oxygen concentrations as low as 0.5% did not alter the growth of HIF-1-proficient or HIF-1-deficient murine fibroblasts, or human tumor cells, despite the appropriate induction of HIF-1 target genes. Severe hypoxia (< 0.01% oxygen) did induced apoptosis, resulting in decreased colony formation, chromatin condensation, DNA fragmentation, and caspase activation but also independent of HIF alpha status. Transcriptional induction of HIF-1-dependent genes putatively involved in cell death like BNip3 and BNip3L was therefore disassociated from hypoxia-dependent toxicity. Likewise, forced overexpression of a nondegradable form of HIF-1 alpha in several human tumor cell lines was not sufficient to induce apoptosis under normoxic conditions. Taken together, these findings indicate that additional molecular events are triggered by anoxia in a HIF-1-independent manner, and these changes are necessary for cell death observed in low-oxygen environments.
引用
收藏
页码:3171 / 3178
页数:8
相关论文
共 45 条
[1]
Alarcon R M, 2001, Novartis Found Symp, V240, P115
[2]
Expression of the gene encoding the proapoptotic Nip3 protein is induced by hypoxia [J].
Bruick, RK .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (16) :9082-9087
[3]
c-Myc sensitization to oxygen deprivation-induced cell death is dependent on Bax/Bak, but is independent of p53 and hypoxia-inducible factor-1 [J].
Brunelle, JK ;
Santore, MT ;
Budinger, GRS ;
Tang, YM ;
Barrett, TA ;
Zong, WX ;
Kandel, E ;
Keith, B ;
Simon, MC ;
Thompson, CB ;
Hay, N ;
Chandel, NS .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (06) :4305-4312
[4]
Role of prolyl hydroxylation in oncogenically stabilized hypoxia-inducible factor-1α [J].
Chan, DA ;
Sutphin, PD ;
Denko, NC ;
Giaccia, AJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2002, 277 (42) :40112-40117
[5]
The E1B 19K Bcl-2-binding protein Nip3 is a dimeric mitochondrial protein that activates apoptosis [J].
Chen, G ;
Ray, R ;
Dubik, D ;
Shi, LF ;
Cizeau, J ;
Bleackley, RC ;
Saxena, S ;
Gietz, RD ;
Greenberg, AH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1997, 186 (12) :1975-1983
[6]
Nix and Nip3 form a subfamily of pro-apoptotic mitochondrial proteins [J].
Chen, G ;
Cizeau, J ;
Velde, CV ;
Park, JH ;
Bozek, G ;
Bolton, J ;
Shi, L ;
Dubik, D ;
Greenberg, A .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (01) :7-10
[7]
Pivotal role of the cell death factor BNIP3 in ceramide-induced autophagic cell death in malignant glioma cells [J].
Daido, S ;
Kanzawa, T ;
Yamamoto, A ;
Takeuchi, H ;
Kondo, Y ;
Kondo, S .
CANCER RESEARCH, 2004, 64 (12) :4286-4293
[8]
Up-regulation of apoptosis inhibitory protein IAP-2 by hypoxia - HIF-1-independent mechanisms [J].
Dong, Z ;
Venkatachalam, MA ;
Wang, JZ ;
Patel, Y ;
Saikumar, P ;
Semenza, GL ;
Force, T ;
Nishiyama, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (22) :18702-18709
[9]
Hypoxia-mediated down-regulation of bid and bax in tumors occurs via hypoxia-inducible factor 1-dependent and -independent mechanisms and contributes to drug resistance [J].
Erler, JT ;
Cawthorne, CJ ;
Williams, KJ ;
Koritzinsky, M ;
Wouters, BG ;
Wilson, C ;
Miller, C ;
Demonacos, C ;
Stratford, IJ ;
Dive, C .
MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (07) :2875-2889
[10]
Hypoxic heterogeneity in human tumors - EF5 binding, vasculature, necrosis, and proliferation [J].
Evans, SM ;
Hahn, SM ;
Magarelli, DP ;
Koch, CJ .
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2001, 24 (05) :467-472